Steven D Marlin

Title: The Innovative Contributions of Steven D. Marlin

Introduction

Steven D. Marlin is a notable inventor based in Danbury, CT (US), recognized for his significant contributions to the field of biomedical research. He holds a total of 11 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents, one is titled "Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV." This invention focuses on intercellular adhesion molecules (ICAM-1), which play a crucial role in how lymphocytes recognize and migrate to sites of inflammation. The invention encompasses molecules, screening assays for identifying them, and antibodies that can bind to these molecules. Another significant patent is "Self-regulated apoptosis of inflammatory cells by gene therapy." This invention involves chimeric nucleic acids that induce apoptosis in activated inflammatory cells. By introducing these chimeric nucleic acids into the cells, the therapeutic potential for treating inflammatory diseases is enhanced.

Career Highlights

Throughout his career, Steven has worked with prestigious organizations, including Dana-Farber Cancer Institute Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. His work in these institutions has contributed to the development of innovative therapies and treatments in the field of inflammation and cancer research.

Collaborations

Steven has collaborated with esteemed colleagues such as Robert Rothlein and Timothy Alan Springer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Steven D. Marlin's contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for innovative solutions to complex medical challenges.